|
TABLE OF CONTENTS
AND LIST OF EXHIBITS
EXECUTIVE SUMMARY
i. Overview of
Selected Cardiovascular Diseases/Disorders
a.
Atherosclerosis
b. Myocardial
Infarction
c. Congestive
Heart Failure
d. Heart Valve
Disorders
e. Congenital
Cardiovascular Defects
ii.
Interventional Cardiology Procedure Volumes and Products Markets
a. Diagnostic
Interventional Cardiology
i. Coronary
Angiography Devices
ii.
Intravascular Ultrasound Systems
iii.
Functional Angiometry Wires
iv.
Intracardiac Ultrasound Systems
b. Therapeutic
Interventional Cardiology
i.
Percutaneous Transluminal Coronary Angioplasty Devices
ii. Coronary
Stents/Stenting Systems
iii.
Mechanical Thrombectomy Systems
iv.
Endovascular Brachytherapy Systems
v. Mechanical
Atherectomy Systems
vi. Laser
Atherectomy Systems
vii. Chronic
Total Occlusion Crossing Systems
viii. Embolic
Protection Systems
ix.
Percutaneous Balloon Valvuloplasty Systems
x.
Transcatheter Septal Defect Repair Systems
xi. Vascular
Access Site Closure Systems
iii. Methodology
Exhibit ES-1:
Incidence and Prevalence Statistics for Selected Cardiovascular
Diseases/Disorders, 2004 and 2009
Exhibit ES-2:
Diagnostic and Therapeutic Interventional Cardiology, Procedure
Volumes Forecast, 2004-2009
Exhibit ES-3:
Diagnostic and Therapeutic Interventional Cardiology Products,
Market Forecast, 2004-2009
Exhibit ES-4:
Diagnostic Interventional Cardiology, Procedure Volumes Forecast,
2004-2009
Exhibit ES-5:
Diagnostic Interventional Cardiology Products, Market Forecast,
2004-2009
Exhibit ES-6:
Coronary Angiography Devices, Market Forecast, 2004-2009
Exhibit ES-7:
Coronary Intravascular Ultrasound Catheter Products, Market
Forecast, 2004-2009
Exhibit ES-8:
Functional Angiometry Wires, Market Forecast, 2004-2009
Exhibit ES-9:
Intracardiac Ultrasound Catheter Products, Market Forecast,
2004-2009
Exhibit ES-10:
Therapeutic Interventional Cardiology, Procedure Volumes Forecast,
2004-2009
Exhibit ES-11:
Therapeutic Interventional Cardiology Products, Market Forecast,
2004-2009
Exhibit ES-12:
Percutaneous Transluminal Coronary Angioplasty Devices, Market
Forecast, 2004-2009
Exhibit ES-13:
Coronary Stents/Stenting Systems, Market Forecast, 2004-2009
Exhibit ES-14:
Coronary Mechanical Thrombectomy Devices, Market Forecast, 2004-2009
Exhibit ES-15:
Coronary Endovascular Brachytherapy Products, Market Forecast,
2004-2009
Exhibit ES-16:
Coronary Mechanical Atherectomy Systems, Market Forecast, 2004-2009
Exhibit ES-17:
Coronary Laser Atherectomy Devices, Market Forecast, 2004-2009
Exhibit ES-18:
Coronary Mechanical Chronic Total Occlusion Crossing Systems, Market
Forecast, 2004-2009
Exhibit ES-19:
Coronary Embolic Protection Systems, Market Forecast, 2004-2009
Exhibit ES-20:
Percutaneous Balloon Valvuloplasty Systems, Market Forecast,
2004-2009
Exhibit ES-21:
Transcatheter Septal Defect Repair Devices, Market Forecast,
2004-2009
Exhibit ES-22:
Vascular Access Site Closure Systems, Market Forecast, 2004-2009
1. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS
1.1 Anatomy and
Physiology of the Heart
1.2 Vascular
Diseases/Disorders
1.2.1 Atherosclerosis
1.2.2 Coronary Heart Disease
1.2.2.1 Angina Pectoris
1.2.2.2 Myocardial Infarction
1.3 Myocardial
Diseases/Disorders
1.3.1 Congestive Heart Failure
1.3.2 Heart Valve Disorders
1.3.3 Congenital Cardiovascular Defects
1.3.4 Rheumatic Fever/Rheumatic Heart Disease
Exhibit 1-1:
Standard Angina Pectoris Classification
Exhibit 1-2:
Incidence and Prevalence Statistics for Selected Vascular
Diseases/Disorders, 2004 and 2009
Exhibit 1-3:
2004, Total Mention Mortality Figures for Selected Vascular
Diseases/Disorders
Exhibit 1-4:
New York Heart Association Classification System for Congestive
Heart Failure
Exhibit 1-5:
Clinical Characteristics of the Most Prevalent Congenital Heart
Defects
Exhibit 1-6:
Incidence and Prevalence Statistics for Selected Myocardial
Diseases/Disorders, 2004 and 2009
Exhibit 1-7:
2004, Total Mention Mortality Figures for Selected Myocardial
Diseases/Disorders
2. INTERVENTIONAL
CARDIOLOGY PROCEDURES
2.1 Diagnostic
Procedures
2.1.1 Coronary Angiography
2.1.1.1 Indications
2.1.1.2 Procedure Volumes Forecast
2.1.2 Intravascular Ultrasound
2.1.2.1 Indications
2.1.2.2 Procedure Volumes Forecast
2.1.3 Functional Angiometry
2.1.3.1 Indications
2.1.3.2 Procedure Volumes Forecast
2.1 4 Intracoronary Angioscopy
2.1.4.1 Indications
2.1.4 2 Procedure Volumes
2.1.5 Intracardiac Ultrasound
2.1.5.1 Indications
2.1.5.2 Procedure Volumes Forecast
2.2 Therapeutic
Procedures
2.2.1
Percutaneous Transluminal Coronary Angioplasty
2.2.1.1 Indications
2.2.1.2 Procedure Volumes Forecast
2.2.2 Coronary
Stenting
2.2.2.1 Characteristics of Coronary Stents
2.2.2.1.1
Coronary Stent Materials, Coatings/Surfaces, and Configurations
2.2.2.1.2
Coronary Stent Delivery and Deployment
2.2.2.1.3
Indications
2.2.2.1.4
Complications
2.2.2.1.5
Coronary Stenting, Caseload Forecast
2.2.2.2
Bare-Metal Stenting versus Drug-Eluting Stenting
2.2.2.2.1
Bare-Metal Stents, Placement Forecast
2.2.2.2.2
Anti-Restenosis Drugs Used in Drug-Eluting Stents
2.2.2.2.3
Anti-Restenosis Drug Delivery Using Drug-Eluting Stents
2.2.2.2.4
Clinical Trials
2.2.2.2.5
Drug-Eluting Stents, Placement Forecast
2.2.2.3
Bare-Metal Stenting Plus Adjuvant Systemic Anti-Restenosis Drug
Therapy
2.2.2.3.1
Indications
2.2.2.3.2
Bare-Metal Stenting Plus Adjuvant Systemic Anti-Restenosis Drug
Therapy, Caseload Forecast
2.2.3 Mechanical
Thrombectomy
2.2.3.1
Indications
2.2.3.2 Procedure
Volumes Forecast
2.2.4
Endovascular Brachytherapy
2.2.4.1
Indications
2.2.4.2 Procedure
Volumes Forecast
2.2.5 Mechanical
Atherectomy
2.2.5.1
Mechanical Atherectomy Techniques
2.2.5.1.1
Directional Atherectomy
2.2.5.1.2
Rotational Atherectomy
2.2.5.1.3
Extraction Atherectomy
2.2.5.2
Indications
2.2.5.3 Procedure
Volumes Forecast
2.2.6 Laser
Atherectomy
2.2.6.1
Indications
2.2.6.2 Procedure
Volumes Forecast
2.2.7 Chronic
Total Occlusion Crossing
2.2.7.1 Current
and Emerging Chronic Total Occlusion Techniques
2.2.7.2 Procedure
Volumes Forecast
2.2.8 Embolic
Protection
2.2.8.1 Embolic
Protection Technologies
2.2.8.1.1 Distal Filtration
2.2.8.1.2 Distal Balloon Occlusion
2.2.8.1.3 Proximal Balloon Occlusion
2.2.8.2
Utilization Trends
2.2.8.3 Procedure
Volumes Forecast
2.2.9
Percutaneous Balloon Valvuloplasty
2.2.9.1
Indications
2.2.9.2 Procedure
Volumes Forecast
2.2.10
Transcatheter Septal Defect Repair
2.2.10.1 Types of Repair
2.2.10.1.1 Patent
Ductus Arteriosus Repair
2.2.10.1.2 Atrial
Septal Defect Repair
2.2.10.1.3
Ventricular Septal Defect Repair
2.2.10.1.4 Patent
Foramen Ovale Repair
2.2.10.2 Procedure Volumes Forecast
2.2.11 Vascular
Access Site Closure
2.2.11.1 Vascular
Access Site Closure Techniques
2.2.11.2 Procedure Volumes Forecast
2.2.12 Vulnerable
Plaque Management
2.2.13 Emerging
Approaches to Plaque Management
2.2.13.1
Cryoplasty
2.2.13.2 Systemic
Biotherapies under Development for the Treatment of Arterial
Atherosclerosis/Inflammation
2.2.13.3
Endovascular Phototherapy
Exhibit 2-1:
Coronary Angiography, Procedure Volumes Forecast, 2004-2009
Exhibit 2-2:
Intravascular Ultrasound, Procedure Volumes Forecast, 2004-2009
Exhibit 2-3:
Functional Angiometry, Procedure Volumes Forecast, 2004-2009
Exhibit 2-4:
Intracardiac Ultrasound, Procedure Volumes Forecast, 2004-2009
Exhibit 2-5:
Percutaneous Transluminal Coronary Angioplasty, Caseload Forecast,
2004-2009
Exhibit 2-6:
Coronary Stenting, Caseload Forecast, 2004-2009
Exhibit 2-7:
Bare-Metal Coronary Stenting, Stent Placement Forecast, 2004-2009
Exhibit 2-8:
Drug-Eluting Stents, Selected Follow-Up Data from Pivotal Clinical
Trials
Exhibit 2-9:
Drug-Eluting Coronary Stenting, Stent Placement Forecast, 2004-2009
Exhibit 2-10:
Bare-Metal Stenting with Adjuvant Anti-Restenosis Drug Therapy,
Caseload Forecast, 2004-2009
Exhibit 2-11:
Coronary Mechanical Thrombectomy, Procedure Volumes Forecast,
2004-2009
Exhibit 2-12:
Coronary Endovascular Brachytherapy, Procedure Volumes Forecast,
2004-2009
Exhibit 2-13:
Coronary Mechanical Atherectomy, Procedure Volumes Forecast,
2004-2009
Exhibit 2-14:
Coronary Laser Atherectomy, Procedure Volumes Forecast, 2004-2009
Exhibit 2-15:
Coronary Mechanical Chronic Total Occlusion Crossing, Procedure
Volumes Forecast, 2004-2009
Exhibit 2-16:
Embolic Protection in Patients Undergoing Percutaneous Coronary
Interventions and Saphenous Vein Grafting, Procedure Volumes
Forecast, 2004-2009
Exhibit 2-17:
Percutaneous Balloon Valvuloplasty, Procedure Volumes Forecast,
2004-2009
Exhibit 2-18:
Transcatheter Septal Defect Repairs, Procedure Volumes Forecast,
2004-2009
Exhibit 2-19:
Vascular Access Site Closure, Procedure Volumes Forecast, 2004-2009
Exhibit 2-20:
2005, Selected Systemic Biotherapies under Development for the
Treatment of Arterial Atherosclerosis/Inflammation
3. INTERVENTIONAL CARDIOLOGY PRODUCTS MARKET
3.1 Diagnostic
Interventional Cardiology Products
3.1.1 Coronary
Angiography Devices
3.1.1.1 Types of Devices
3.1.1.1.1 Angiography Catheters
3.1.1.1.2 Diagnostic Guidewires
3.1.1.1.3 Sheaths
3.1.1.1.4 Angiography Accessories
3.1.1.2 Products
3.1.1.3 Market Forecast
3.1.1.4 Competitive Analysis
3.1.2
Intravascular Ultrasound Systems
3.1.2.1 Products
3.1.2.2 Market Forecast
3.1.2.3 Competitive Analysis
3.1.3 Functional
Angiometry Wires
3.1.3.1 Products
3.1.3.2 Market Forecast
3.1.4
Intracardiac Ultrasound Systems
3.1.4.1 Products
3.1.4.2 Market Forecast
3.1.4.3 Competitive Analysis
3.2 Therapeutic
Interventional Cardiology Products
3.2.1
Percutaneous Transluminal Coronary Angioplasty Products
3.2.1.1 Types of Devices
3.2.1.1.1 Balloon Catheters
3.2.1.1.2 Guiding Catheters
3.2.1.1.3 Therapeutic Guidewires
3.2.1.1.4 Introducers/Sheaths
3.2.1.1.5 Inflation Devices
3.2.1.2 Market Forecast
3.2.1.3 Competitive Analysis
3.2.2 Coronary
Stenting Systems
3.2.2.1 Products
3.2.2.1.1
Bare-Metal Coronary Stent Products
3.2.2.1.2
Drug-Eluting Coronary Stent Products
3.2.2.1.2.1
Sirolimus-Eluting Stents/Stenting Systems
3.2.2.1.2.2
Paclitaxel-Eluting Stents/Stenting Systems
3.2.2.1.2.3
Everolimus-Eluting Stents/Stenting Systems
3.2.2.1.2.4
ABT-578-Eluting Stents/Stenting Systems
3.2.2.1.2.5
AP23573-Eluting Stents/Stenting Systems
3.2.2.1.2.6
Tacrolimus-Eluting Stents/Stenting Systems
3.2.2.1.2.7
Biolimus A9-Eluting Stents/Stenting Systems
3.2.2.1.2.8 Other
Coronary Stents/Stenting Systems
3.2.2.2 Market Forecast
3.2.2.3 Competitive Analysis
3.2.3 Mechanical
Thrombectomy Systems
3.2.3.1 Products
3.2.3.2 Market Forecast
3.2.4
Endovascular Brachytherapy Systems
3.2.4.1 Products
3.2.4.2 Market Forecast
3.2.5 Mechanical
Atherectomy Systems
3.2.5.1 Products
3.2.5.2 Market Forecast
3.2.5.3 Competitive Analysis
3.2.6 Laser
Atherectomy Systems
3.2.6.1 Products
3.2.6.2 Market Forecast
3.2.7 Chronic
Total Occlusion Crossing Systems
3.2.7.1 Products
3.2.7.2 Market Forecast
3.2.7.3 Competitive Analysis
3.2.8 Embolic
Protection Systems
3.2.8.1 Products
3.2.8.2 Market Forecast
3.2.8.3 Competitive Analysis
3.2.9
Percutaneous Balloon Valvuloplasty Systems
3.2.9.1 Products
3.2.9.2 Market Forecast
3.2.9.3 Competitive Analysis
3.2.10
Transcatheter Septal Defect Repair Systems
3.2.10.1 Products
3.2.10.2 Market Forecast
3.2.10.3 Competitive Analysis
3.2.11 Vascular
Access Site Closure Systems
3.2.11.1 Products
3.2.11.2 Market Forecast
3.2.11.3 Competitive Analysis
Exhibit 3-1:
Diagnostic and Therapeutic Interventional Cardiology, Procedure
Volumes Forecast, 2004-2009
Exhibit 3-2:
Diagnostic and Therapeutic Interventional Cardiology Products,
Market Forecast, 2004-2009
Exhibit 3-3:
Diagnostic Interventional Cardiology, Procedure Volumes Forecast,
2004-2009
Exhibit 3-4:
Diagnostic Interventional Cardiology Products, Market Forecast,
2004-2009
Exhibit 3-5:
Coronary Angiography, Average Transcatheter Device Usage
Exhibit 3-6:
2005, Selected Coronary Angiography Catheters
Exhibit 3-7:
Coronary Angiography Devices, Market Forecast, 2004-2009
Exhibit 3-8:
2004, Coronary Angiography Devices Market, Share by Supplier
Exhibit 3-9:
2005, Selected Coronary Intravascular Ultrasound Catheter Products
Exhibit 3-10:
Coronary Intravascular Ultrasound Catheter Products, Market
Forecast, 2004-2009
Exhibit 3-11:
2004, Coronary Intravascular Ultrasound Catheter Products Market,
Share by Supplier
Exhibit 3-12:
2005, Selected Functional Angiometry Wires
Exhibit 3-13:
Functional Angiometry Wires, Market Forecast, 2004-2009
Exhibit 3-14:
2005, Selected Intracardiac Ultrasound Catheter Products
Exhibit 3-15:
Intracardiac Ultrasound Catheter Products, Market Forecast,
2004-2009
Exhibit 3-16:
2004, Intracardiac Ultrasound Catheter Products, Share by Supplier
Exhibit 3-17:
Therapeutic Interventional Cardiology, Procedure Volumes Forecast,
2004-2009
Exhibit 3-18:
Therapeutic Interventional Cardiology Products, Market Forecast,
2004-2009
Exhibit 3-19:
Percutaneous Transluminal Coronary Angioplasty, Average
Transcatheter Device Usage
Exhibit 3-20:
2005, Selected Percutaneous Transluminal Coronary Angioplasty
Balloon Catheters
Exhibit 3-21:
2005, Selected Coronary Guiding Catheters
Exhibit 3-22:
2005, Selected Coronary Guidewires for Therapeutic Procedures
Exhibit 3-23:
2005, Selected Introducers/Sheaths
Exhibit 3-24:
2005, Selected Inflation Devices
Exhibit 3-25:
Percutaneous Transluminal Coronary Angioplasty Devices, Market
Forecast, 2004-2009
Exhibit 3-26:
2004, Percutaneous Transluminal Coronary Angioplasty Devices Market,
Share by Supplier
Exhibit 3-27:
2005, Selected Coronary Stents/Stenting Systems
Exhibit 3-28:
Coronary Stents/Stenting Systems, Market Forecast, 2004-2009
Exhibit 3-29:
2004, Coronary Stents/Stenting Systems, Share by Supplier
Exhibit 3-30:
Coronary Mechanical Thrombectomy Devices, Market Forecast, 2004-2009
Exhibit 3-31:
Coronary Endovascular Brachytherapy Products, Market Forecast,
2004-2009
Exhibit 3-32:
2005, Selected Coronary Mechanical Atherectomy Systems
Exhibit 3-33:
Coronary Mechanical Atherectomy Systems, Market Forecast, 2004-2009
Exhibit 3-34:
2004, Coronary Mechanical Atherectomy Systems, Share by Supplier
Exhibit 3-35:
Coronary Laser Atherectomy Devices, Market Forecast, 2004-2009
Exhibit 3-36:
2005, Selected Chronic Total Occlusion Crossing Systems
Exhibit 3-37:
Coronary Mechanical Chronic Total Occlusion Crossing Systems, Market
Forecast, 2004-2009
Exhibit 3-38:
2004, Coronary Mechanical Chronic Total Occlusion Crossing Systems,
Share by Supplier
Exhibit 3-39:
2005, Selected Coronary Embolic Protection Systems
Exhibit 3-40:
Coronary Embolic Protection Systems, Market Forecast, 2004-2009
Exhibit 3-41:
2004, Embolic Protection Systems Market, Share by Supplier
Exhibit 3-42:
2005, Selected Percutaneous Balloon Valvuloplasty Systems
Exhibit 3-43:
Percutaneous Balloon Valvuloplasty Systems, Market Forecast,
2004-2009
Exhibit 3-44:
2004, Percutaneous Balloon Valvuloplasty Systems Market, Share by
Supplier
Exhibit 3-45:
2005, Selected Transcatheter Septal Defect Repair Systems
Exhibit 3-46:
Transcatheter Septal Defect Repair Devices, Market Forecast,
2004-2009
Exhibit 3-47:
2004, Transcatheter Septal Defect Repair Devices Market, Share by
Supplier
Exhibit 3-48:
2005, Selected Vascular Access Site Closure Systems
Exhibit 3-49:
Vascular Access Site Closure Systems, Market Forecast, 2004-2009
Exhibit 3-50:
2004, Vascular Access Site Closure Systems Market, Share by Supplier
4. COMPANY
PROFILES
4.1 Abbott Laboratories
4.2
AGA Medical
Corporation
4.3 B. Braun Melsungen AG
4.4
Boston Scientific
Corporation
4.5 Cordis Corporation/Johnson & Johnson
4.6 EPMedSystems, Inc.
4.7 Guidant Corporation
4.8 IntraLuminal Therapeutics, Inc.
4.9 LuMend, Inc./Johnson & Johnson
4.10 Medtronic, Inc.
4.11 NMT Medical, Inc.
4.12 Possis Medical, Inc.
4.13 Siemens Medical Solutions, Inc./Siemens AG
4.14 Spectranetics Corporation
4.15 St. Jude Medical, Inc.
4.16 Toray Medical Co.,
LTD/Toray Industries, Inc./Toray Group
4.17 Volcano Therapeutics, Inc.
APPENDIX: COMPANY LISTING
Copyright 2005,
Medtech Insight, LLC |
